DIMED (PNVL3) Main Indicators
Basic Data - PNVL3
| Company | DIMED |
| Corporate Name | DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Comercio atacadista e varejista de medicamentos e produtos de perfumaria e toucador |
| Share | PNVL3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 9.70 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.84 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 11/21/2024 | |
Relative Prices - PNVL3
| Price/Earnings | 14.09 |
| Price/SBV | 1.22 |
| Price/Net Sales | 0.30 |
| Price/CFO | 5.31 |
| Price/FCF | 9.26 |
| Price/Total Assets | 0.45 |
| Price/EBIT | 7.99 |
| Price/Working Capital | 2.03 |
| Price/NCAV | -1.11 |
| EV/EBIT | 14.18 |
| EV/EBITDA | 6.65 |
| EV/Net Sales | 0.54 |
| EV/CFO | 9.44 |
| EV/FCF | 16.44 |
| EV/Total Assets | 0.80 |
| Company Market Cap | R$ 1.46 B |
| Enterprise Value | R$ 2.59 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 9.70 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 4.52% |
| Updated 11/21/2024 | |
Income Statement - PNVL3
| Net Revenue | R$ 4.82 B |
| Gross Result | R$ 1.52 B |
| EBIT | R$ 182.67 M |
| Depreciation and Amortization | - R$ 206.59 M |
| EBITDA | R$ 389.26 M |
| Net Profit | R$ 103.55 M |
| Net Profit/Share | R$ 0.69 |
| Updated 11/13/2024 | |
| Net Revenue | R$ 1.24 B |
| Gross Result | R$ 390.04 M |
| EBIT | R$ 63.17 M |
| Depreciation and Amortization | - R$ 52.30 M |
| EBITDA | R$ 115.46 M |
| Net Profit | R$ 35.86 M |
| Profit/Share | R$ 0.24 |
| Updated 11/13/2024 | |
Price and Volume Behavior - PNVL3
| Lowest Price 52 weeks | R$ 9.40 |
| Highest Price 52 weeks | R$ 13.06 |
| Variation 2024 | -24.56% |
| Variation 1 year | -15.76% |
| Variation 2 years(total) | -5.87% |
| Variation 2 years(yearly) | -2.97% |
| Variation 3 years(total) | -19.74% |
| Variation 3 years(yearly) | -7.06% |
| Variation 4 years(total) | -52.95% |
| Variation 4 years(yearly) | -17.18% |
| Variation 5 years(total) | -40.79% |
| Variation 5 years(yearly) | -9.89% |
| Average Daily Volume (3 months) | R$ 3.19 M |
| Updated 11/21/2024 | |
Returns and Margins - PNVL3
| Return on Initial Tangible Capital | 5.67% |
| Return on Initial Invested Capital | 5.48% |
| Pre-Tax Return on Initial Tangible Capital | 8.59% |
| Pre-Tax Return on Initial Invested Capital | 8.31% |
| Return on Initial Shareholder´s Equity | 9.09% |
| Return on Initial Asset | 3.52% |
| Gross Margin | 31.64% |
| Net Margin | 2.15% |
| EBIT Margin | 3.79% |
| EBITDA Margin | 8.08% |
| Initial Asset Turnover | 1.64 |
| Financial Leverage | 2.70 |
| Liabilities/Net Worth | 1.70 |
| Net Debt/EBITDA | 2.91 |
| Updated 11/13/2024 | |
Balance Sheet - PNVL3
| Cash and Cash Equivalents | R$ 12.18 M |
| Total Assets | R$ 3.23 B |
| Short-Term Debt | R$ 325.88 M |
| Long-Term Debt | R$ 817.96 M |
| Gross Debt | R$ 1.14 B |
| Net Debt | R$ 1.13 B |
| Shareholder´s Equity | R$ 1.20 B |
| Share Book Value | R$ 7.95 |
| Common Shares | 150,377,841 |
| Preferred Shares | 0 |
| Total | 150,377,841 |
| Common Shares in Treasury | 1,019,944 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,019,944 |
| Common Shares (Except Treasury) | 149,357,897 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 149,357,897 |
| Updated 11/13/2024 | |
Cash Flow - PNVL3
| Operating Cash Flow | R$ 274.49 M |
| Cash Flow from Investments | - R$ 60.93 M |
| Financing Cash Flow | - R$ 216.97 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 3.40 M |
| Updated 11/13/2024 | |
| Operating Cash Flow | R$ 30.83 M |
| Cash Flow from Investments | R$ 18.04 M |
| Financing Cash Flow | - R$ 53.39 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 4.53 M |
| Updated 11/13/2024 | |
Experimental - PNVL3
| CAPEX 3 months | - R$ 45.09 M |
| Free Cash Flow 3 months | - R$ 14.26 M |
| CAPEX 12 months | - R$ 116.94 M |
| Free Cash Flow 12 months | R$ 157.55 M |
| Updated 11/13/2024 | |